Renal function during long-term lithium treatment: a cross-sectional and longitudinal study
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of lithium treatment on renal function have been previously shown, albeit with discrepancies regarding their relevance. In this study, we examined glomerular filtration rate in patients treated with lithium for up to 33 years. METHODS: All lithium patients registered from 1980 to 2012 at a Lithium Clinic were screened. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine concentration using the Modification of Diet in Renal Disease Study Group equation. A cross-sectional evaluation of the last available eGFR of 953 patients was carried out using multivariate regression analysis for gender, current age, and duration of lithium treatment. Survival analysis was subsequently applied to calculate the time on lithium needed to enter the eGFR ranges 45 to 59 mL/min/1.73 m² (G3a) or 30 to 44 mL/min/1.73 m² (G3b). Finally, 4-year follow-up of eGFR was examined in subgroups of patients who, after reduction to an eGFR lower than 45 mL/min/1.73 m² either i) continued lithium at the same therapeutic range or ii) discontinued lithium or continued at concentrations below the therapeutic range (0.5 mmol/L). RESULTS: In the cross-sectional evaluation, eGFR was found to be lower in women (by 3.47 mL/min/1.73 m²), in older patients (0.73 mL/min/1.73 m² per year of age), and in patients with longer lithium treatment (0.73 mL/min/1.73 m² per year). Half of the patients treated for longer than 20 years had an eGFR lower than 60 mL/min/1.73 m². The median time on lithium taken to enter G3a or G3b was 25 years (95% CI, 23.2-26.9) and 31 years (95% CI, 26.6-35.4), respectively. Progression of renal failure throughout the 4-year follow-up after a reduction to an eGFR lower than 45 mL/min/1.73 m² did not differ between the subgroup who continued lithium as before and the subgroup who either discontinued lithium or continued at concentrations below the therapeutic range. CONCLUSIONS: Duration of lithium treatment is to be added to advancing age as a risk factor for reduced glomerular filtration rate. However, renal dysfunction tends to appear after decades of treatment and to progress slowly and irrespective of lithium continuation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Instances of lithium toxicity will also greatly increase risk of renal dysfunction.821”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [821]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 877 · cited 2×
“However, some concerns have frequently been raised about its safety [4].”
BackgroundGeddes, J. R., Burgess, S., Hawton, K., Jamison, K., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.217 · Cited by 661 · cited 1×
“Background Lithium is the most effective long-term therapy for bipolar disorder [1,2] and is also effective in unipolar depression [3].”
BackgroundCipriani, A., Pretty, H., Hawton, K., & Geddes, J. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1805 · Cited by 617 · cited 1×
“Indeed, the benefits obtained from lithium must be regarded not only in terms of stabilization of recurrent mood disorders, but also in normalization of their otherwise increased mortality, mainly due to suicide [24-26].”
BackgroundLithium toxicity profi le: a systematic review and meta-analysis
McKnight, R. F., Budge, K., Ba, S., Goodwin, G. M., Geddes, J. R., & Adida, M. (2012) · Cited by 544
Earley, A., Miskulin, D., Lamb, E. J., Levey, A. S., & Uhlig, K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201203200-00391 · Cited by 487 · cited 4×
“An advance in epidemiological surveys of large populations was represented by the demonstrated reliability of eGFR calculated from routine laboratory determinations of serum creatinine [7,8].”
MethodInfluentialChronic renal lesions following long-term treatment with lithium
Hestbech, J., Hansen, H. E., Amdisen, A., & Olsen, S. (1977) · Kidney International · doi:10.1038/ki.1977.102 · Cited by 403 · cited 1×
“Nevertheless, adverse renal effects of lithium have long been known, varying from very frequent reversible polyuria [12] to irreversible kidney damage [13,14].”
BackgroundPrevalence, Pathogenesis, and Treatment of Renal Dysfunction Associated With Chronic Lithium Therapy
Boton, R., Gaviria, M., & Batlle, D. C. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80098-7 · Cited by 353 · cited 2×
“survey, but, in any case, rates can be considered impressive as compared to the 15% prevalence calculated by the review of earlier studies of unselected patients on chronic lithium [16].”
BackgroundResult
Research works printed but not linked: 1
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Lithium side effects and toxicity: prevalence and management strategies
Gitlin, M. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0068-y · Cited by 531
“Risk factors for lithium-induced nephropathy are length of treatment, age, and prior episodes of lithium toxicity (Aiff et al. 2015; Bocchetta et al. 2015; Clos et al. 2015).”
BackgroundIncidence of Cancer in Patients with Chronic Heart Failure: A Long-Term Follow-Up Study
Banke, A., Schou, M., Videbæk, L., Møller, J. E., Torp-Pedersen, C., Gustafsson, F., Dahl, J. S., Køber, L., Hildebrandt, P. R., & Gislason, G. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.472 · Cited by 235
Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., Calkin, C. V., Chillotti, C., Hidalgo-Mazzei, D., Manchia, M., et al. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0096-2 · Cited by 125
Self-citationOtt, M., Stegmayr, B. G., Renberg, E. S., & Werneke, U. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116652577 · Cited by 122
“Long-term lithium use is associated with an increased risk of loss of renal function (Bocchetta et al., 2015; Close et al., 2014).”
Background
Metadata
- Authors
- Bocchetta, A., Ardau, R., Fanni, T., Sardu, C., Piras, D., Pani, A., & Del Zompo, M.
- Affiliations
- University of Cagliari (IT)
- Azienda Ospedaliero-Universitaria Cagliari (IT)
- Azienda Ospedaliera G. Brotzu (IT)
- Corresponding author
- Bocchetta, Alberto
- Venue
- BMC Medicine
- Published
- 2015-01-21
- Volume
- 13
- Issue
- 1
- Pages
- 12-12
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC4300557
- OpenAlex
- W1985028928
- Cited by
- 77
- References
- 30
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 10 · 2017: 12 · 2016: 9 · 2015: 4
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- lithium, glomerular filtration rate, renal function, long-term lithium therapy, chronic kidney disease, renal failure, age as risk factor, bipolar disorder, estimated glomerular filtration rate, serum creatinine, lithium nephrotoxicity
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Creatinine, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Lithium, Longitudinal Studies, Male, Middle Aged, Risk Factors, Antipsychotic Agents, Disease Progression, Renal Insufficiency, Chronic, Renal Insufficiency, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. https://app.cochat.ai/papers/10.1186/s12916-014-0249-4
- The paper
- Bocchetta, A., Ardau, R., Fanni, T., Sardu, C., Piras, D., Pani, A., & Del Zompo, M. (2015). Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Medicine. https://doi.org/10.1186/s12916-014-0249-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.